Karla Flores had a tumor strangling her spinal cord near the base of her skull. Doctors weighed whether they should attempt a ...

Gastric cancer remains a major health challenge worldwide, with nearly 1 million new cases annually contributing to more than ...

Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that a phase II/III clinical trial of anti-HER2 bispecific antibody ...

An immuno-based treatment targeting cancer cells with mismatch repair-deficiency could help those with the disease treat ...

Participants in the trial were all patients with tumors ranging from stage 1 to stage 3, meaning the tumors had not yet spread, the release indicated.

Dostarlimab offers hope in cancer treatment. Study shows tumour shrinkage in patients with mismatch repair defect. Some ...

This innovative approach challenges the standard treatment path for many cancer patients, which typically includes surgery followed by chemotherapy and radiation. For patients facing difficult ...

New research shows 92% of cancer patients stayed cancer-free for two years after immune-based therapy, potentially avoiding surgery and harsh treatments.

A "groundbreaking" cancer treatment trial by Memorial Sloan Kettering shows immunotherapy alone can eliminate some tumors, ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

New results from a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK), gastrointestinal oncologists Andrea ...